1ST tier newborn screening kits
Ended Purchase Order Awarded
- Contract number
- 75D30125P20580
- Awardee
-
Cambridge Isotope Laboratories, Inc. UEI JNBGUL51AVL8
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $221,095
Award facts
- Opportunity
-
- 1st Tier NBS IS Solicitation · 75D30125Q78685 · Posted Aug 29, 2025
- Contract value 100% obligated
- $221,095.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Andover, MA 01810, USA
Award details come from SAM.gov/FPDS.
About this award
The Centers for Disease Control and Prevention (CDC) awarded Cambridge Isotope Laboratories, Inc. a $221,095 firm fixed-price purchase order on September 23, 2025, for the supply of five First Tier Newborn Screening Internal Standard Kits. These specialized kits consist of lyophilized mixtures of isotopically labeled internal standards with 97% or higher chemical purity, designed for accurate quantification of first-tier newborn screening analytes using mass spectrometry analysis. Each kit contains 10 vials of resuspendable internal standard mixture with a minimum stability period of six months under specified storage conditions. The contract was awarded without set-aside designation based on a lowest-priced technically acceptable basis, with delivery required to the CDC Distribution Center in Chamblee, Georgia, by January 15, 2026.
Cambridge Isotope Laboratories, headquartered in Andover, Massachusetts, is a foreign-owned manufacturer specializing in stable isotopes and isotope-labeled compounds for scientific and medical research. The company maintains a significant $10 million Blanket Purchase Agreement with the National Institutes of Health (NIH) Office of Logistics and Acquisition Operations running through January 2026, and has an established history of providing specialized isotopic materials to multiple federal agencies. This CDC contract aligns with the company's core competency in producing high-purity isotopic compounds for biomedical research and diagnostic applications, with ultimate completion targeted for March 23, 2026.
Quick answers
Who was awarded contract 75D30125P20580?
75D30125P20580 was awarded to Cambridge Isotope Laboratories, Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 23, 2025.
How much is contract 75D30125P20580 worth?
The government has obligated $221,095 on 75D30125P20580.
Was contract 75D30125P20580 competed?
The extent of competition for 75D30125P20580 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award